Related references
Note: Only part of the references are listed.Revised criteria for diagnosis of Alzheimer's disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease
Zaven S. Khachaturian
ALZHEIMERS & DEMENTIA (2011)
Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2011)
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
Commentary on Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Addressing the challenge of Alzheimer's disease in the 21st century
Karl Herrup
ALZHEIMERS & DEMENTIA (2011)
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Reisa A. Sperling et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Amyloid-β Associated Volume Loss Occurs Only in the Presence of Phospho-Tau
Rahul S. Desikan et al.
ANNALS OF NEUROLOGY (2011)
Amyloid-β Associated Cortical Thinning in Clinically Normal Elderly
J. Alex Becker et al.
ANNALS OF NEUROLOGY (2011)
Cognitively Preserved Subjects with Transitional Cerebrospinal Fluid β-Amyloid 1-42 Values Have Thicker Cortex in Alzheimer's Disease Vulnerable Areas
Juan Fortea et al.
BIOLOGICAL PSYCHIATRY (2011)
Independent contribution of temporal β-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease
Gael Chetelat et al.
BRAIN (2011)
Biomarkers Predicting Alzheimer's Disease in Cognitively Normal Aging
Yong S. Shim et al.
JOURNAL OF CLINICAL NEUROLOGY (2011)
Early detection of Alzheimer disease 11C-PiB PET in twins discordant for cognitive impairment
N. M. Scheinin et al.
NEUROLOGY (2011)
Predicting MCI outcome with clinically available MRI and CSF biomarkers
D. Heister et al.
NEUROLOGY (2011)
Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
Kerryn E. Pike et al.
NEUROPSYCHOLOGIA (2011)
Neuroprotective therapeutics for Alzheimer's disease: progress and prospects
Alan M. Palmer
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Update on the Magnetic Resonance Imaging core of the Alzheimer's Disease Neuroimaging Initiative
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2010)
Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimer Disease
K. B. Walhovd et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Larger temporal volume in elderly with high versus low beta-amyloid deposition
Gael Chetelat et al.
BRAIN (2010)
Brain Atrophy in Healthy Aging Is Related to CSF Levels of Aβ1-42
Anders M. Fjell et al.
CEREBRAL CORTEX (2010)
Amyloid beta and APP as biomarkers for Alzheimer's disease
Henrik Zetterberg et al.
EXPERIMENTAL GERONTOLOGY (2010)
CSF Biomarkers in Prediction of Cerebral and Clinical Change in Mild Cognitive Impairment and Alzheimer's Disease
Anders M. Fjell et al.
JOURNAL OF NEUROSCIENCE (2010)
Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis
Sanjay W. Pimplikar et al.
JOURNAL OF NEUROSCIENCE (2010)
Reimagining Alzheimer's Disease-An Age-Based Hypothesis
Karl Herrup
JOURNAL OF NEUROSCIENCE (2010)
Alzheimer's disease: progress in prediction
Ronald C. Petersen
LANCET NEUROLOGY (2010)
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Clifford R. Jack et al.
LANCET NEUROLOGY (2010)
Boosting power for clinical trials using classifiers based on multiple biomarkers
Omid Kohannim et al.
NEUROBIOLOGY OF AGING (2010)
Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: a longitudinal MRI study
Duygu Tosun et al.
NEUROBIOLOGY OF AGING (2010)
Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study
Jasper D. Sluimer et al.
NEUROBIOLOGY OF AGING (2010)
Are A beta and Its Derivatives Causative Agents or Innocent Bystanders in AD?
Nikolaos K. Robakis
NEURODEGENERATIVE DISEASES (2010)
CSF biomarker pathology correlates with a medial temporo-parietal network affected by very mild to moderate Alzheimer's disease but not a fronto-striatal network affected by healthy aging
Anders M. Fjell et al.
NEUROIMAGE (2010)
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
P. Bourgeat et al.
NEUROLOGY (2010)
Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease
Kwasi G. Mawuenyega et al.
SCIENCE (2010)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B
Martha Storandt et al.
ARCHIVES OF NEUROLOGY (2009)
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease
Clifford R. Jack et al.
BRAIN (2009)
Structural MRI Biomarkers for Preclinical and Mild Alzheimer's Disease
Christine Fennema-Notestine et al.
HUMAN BRAIN MAPPING (2009)
Reassessing the amyloid cascade hypothesis of Alzheimer's disease
Sanjay W. Pimplikar
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
The amyloid hypothesis for Alzheimer's disease: a critical reappraisal
John Hardy
JOURNAL OF NEUROCHEMISTRY (2009)
One-Year Brain Atrophy Evident in Healthy Aging
Anders M. Fjell et al.
JOURNAL OF NEUROSCIENCE (2009)
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Anatoly Nikolaev et al.
NATURE (2009)
Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease
Joseph L. Price et al.
NEUROBIOLOGY OF AGING (2009)
Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area
Bradford C. Dickerson et al.
NEUROBIOLOGY OF AGING (2009)
The cortical signature of prodromal AD Regional thinning predicts mild AD dementia
Akram Bakkour et al.
NEUROLOGY (2009)
MRI and CSF biomarkers in normal, MCI, and AD subjects Diagnostic discrimination and cognitive correlations
P. Vemuri et al.
NEUROLOGY (2009)
Regional rates of neocortical atrophy from normal aging to early Alzheimer disease
C. R. McDonald et al.
NEUROLOGY (2009)
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI
I. Driscoll et al.
NEUROLOGY (2009)
MRI and CSF biomarkers in normal, MCI, and AD subjects Predicting future clinical change
P. Vemuri et al.
NEUROLOGY (2009)
Alzheimer Disease: Quantitative Structural Neuroimaging for Detection and Prediction of Clinical and Structural Changes in Mild Cognitive Impairment
Linda K. McEvoy et al.
RADIOLOGY (2009)
Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment
A. M. Fjell et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2008)
Alzheimer's disease sends the wrong signals - a perspective
Rachael L. Neve
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2008)
IIC PiB and structural MRI provide complementary information in imaging of Alzheimers disease and amnestic mild cognitive impairment
Clifford R. Jack et al.
BRAIN (2008)
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Milos D. Ikonomovic et al.
BRAIN (2008)
Cerebrospinal fluid tau and amyloid beta 42 protein in patients with myotonic dystrophy type 1
S. Winblad et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
CSF levels of β-amyloid 1-42, tau and phosphorylated tau protein in CADASIL
P. Formichi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
The value of incomplete mouse models of Alzheimer's disease
Rebecca Radde et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Targeted proteomics in Alzheimer's disease: focus on amyloid-beta
Erik Portelius et al.
EXPERT REVIEW OF PROTEOMICS (2008)
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg et al.
NEUROBIOLOGY OF AGING (2008)
Atrophy rates accelerate in amnestic mild cognitive impairment
C. R. Jack et al.
NEUROLOGY (2008)
Molecular imaging with Pittsburgh compound B confirmed at autopsy - A case report
Brian J. Bacskai et al.
ARCHIVES OF NEUROLOGY (2007)
Amyloid, hypometabolism, and cognition in Alzheimer disease - An [11C]PIB and [18F]FDG PET study
P. Edison et al.
NEUROLOGY (2007)
Early detection of Alzheimer's disease using neuroimaging
Lisa Mosconi et al.
EXPERIMENTAL GERONTOLOGY (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Spatial patterns of cortical thinning in mild cognitive impairment and Alzheimer's disease
Vivek Singh et al.
BRAIN (2006)
Synapse formation and function is modulated by the amyloid precursor protein
Christina Priller et al.
JOURNAL OF NEUROSCIENCE (2006)
Neuropathology of older persons without cognitive impairment from two community-based studies
D. A. Bennett et al.
NEUROLOGY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
MJ de Leon et al.
NEUROBIOLOGY OF AGING (2006)
Healthy and pathological processes in adult development: new evidence from neuroimaging of the aging brain
T Hedden et al.
CURRENT OPINION IN NEUROLOGY (2005)
Amyloid-β in Alzheimer's disease:: the horse or the cart?: Pathogenic or protective?
HG Lee et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2005)
Predictors of-preclinical Alzheimer disease and dementia - A clinicopathologic study
JE Galvin et al.
ARCHIVES OF NEUROLOGY (2005)
Natural oligomers of the amyloid-protein specifically disrupt cognitive function
JP Cleary et al.
NATURE NEUROSCIENCE (2005)
Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration
CA Saura et al.
NEURON (2004)
ApoE and clusterin cooperatively suppress Aβ levels and deposition:: Evidence that ApoE regulates extracellular Aβ metabolism in vivo
RB DeMattos et al.
NEURON (2004)
MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD
L deToledo-Morrell et al.
NEUROBIOLOGY OF AGING (2004)
Memory and executive function in aging and AD: Multiple factors that cause decline and reserve factors that compensate
RL Buckner
NEURON (2004)
Spatial representation in the entorhinal cortex
M Fyhn et al.
SCIENCE (2004)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Resting-state brain glucose utilization as measured by PET is directly related to regional synaptophysin levels: a study in baboons
AB Rocher et al.
NEUROIMAGE (2003)
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
DR Thal et al.
NEUROLOGY (2002)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain
B Fischl et al.
NEURON (2002)
The cognitive neuroscience of remembering
RL Buckner et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
J Lewis et al.
SCIENCE (2001)
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
J Lewis et al.
NATURE GENETICS (2000)
Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline
J Näslund et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
